Phil Gingrey: “Encouraging drug development to combat infections that arise from Gram-negative pathogens like Iraqibacter is an…”

Let me first commend Chairman Upton and our colleague from Colorado, Ms. DeGette, for spearheading this bipartisan endeavor.

I really have to commend the FDA on that and realizing the desire and need for new antibiotics and acting quickly to implement the program.

As educators and legislators, we must not neglect our duties to equip these young people, our children, these students, with the tools and the knowledge to build a successful career.

It made no sense to cut $300 billion out of a program that 29 percent of Medicare beneficiaries had chosen.